Genetic testing company Natera (NASDAQ: NTRA) will be announcing earnings results this Thursday after the bell. Here’s what to expect.
Natera beat analysts’ revenue expectations last quarter, reporting revenues of $752.8 million, up 37.7% year on year. It was a stunning quarter for the company, with full-year revenue guidance exceeding analysts’ expectations and a beat of analysts’ EPS estimates.
Is Natera a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Natera’s revenue to grow 19.8% year on year, slowing from the 34.7% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Natera has a history of exceeding Wall Street’s expectations.
Looking at Natera’s peers in the biotechnology segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Regeneron delivered year-on-year revenue growth of 36.3%, beating analysts’ expectations by 11.1%, and Incyte reported revenues up 14%, topping estimates by 6.5%. Regeneron traded up 17.4% following the results while Incyte was also up 3%.
Read our full analysis of Regeneron’s results here and Incyte’s results here.
There has been positive sentiment among investors in the biotechnology segment, with share prices up 2.8% on average over the last month. Natera is down 8.6% during the same time and is heading into earnings with an average analyst price target of $416.39 (compared to the current share price of $388.98).
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
